Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hormone replacement therapy: a time for pause.

× No keyword cloud information.

24 in total

1. Menopause, local biologies, and cultures of aging.

Authors: M Lock; P Kaufert
Journal: Am J Hum Biol Date: 2001 Jul-Aug Impact factor: 1.937

Review 2. A critique of the grandmother hypotheses: old and new.

Authors: J S Peccei
Journal: Am J Hum Biol Date: 2001 Jul-Aug Impact factor: 1.937

3. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.

Authors:
Journal: Lancet Date: 1997-10-11 Impact factor: 79.321

4. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review.

Authors: A MacLennan; S Lester; V Moore
Journal: Climacteric Date: 2001-03 Impact factor: 3.005

5. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

Authors: D M Herrington; D M Reboussin; K B Brosnihan; P C Sharp; S A Shumaker; T E Snyder; C D Furberg; G J Kowalchuk; T D Stuckey; W J Rogers; D H Givens; D Waters
Journal: N Engl J Med Date: 2000-08-24 Impact factor: 91.245

6. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.

Authors: C L Loprinzi; J W Kugler; J A Sloan; J A Mailliard; B I LaVasseur; D L Barton; P J Novotny; S R Dakhil; K Rodger; T A Rummans; B J Christensen
Journal: Lancet Date: 2000-12-16 Impact factor: 79.321

7. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.

Authors: F Grodstein; J E Manson; G A Colditz; W C Willett; F E Speizer; M J Stampfer
Journal: Ann Intern Med Date: 2000-12-19 Impact factor: 25.391

8. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.

Authors: K J Pandya; R F Raubertas; P J Flynn; H E Hynes; R J Rosenbluth; J J Kirshner; H I Pierce; V Dragalin; G R Morrow
Journal: Ann Intern Med Date: 2000-05-16 Impact factor: 25.391

9. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Authors: S R Cummings; S Eckert; K A Krueger; D Grady; T J Powles; J A Cauley; L Norton; T Nickelsen; N H Bjarnason; M Morrow; M E Lippman; D Black; J E Glusman; A Costa; V C Jordan
Journal: JAMA Date: 1999-06-16 Impact factor: 56.272

10. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.

Authors: G A Greendale; B A Reboussin; P Hogan; V M Barnabei; S Shumaker; S Johnson; E Barrett-Connor
Journal: Obstet Gynecol Date: 1998-12 Impact factor: 7.661

7 in total

1. Reserving judgement on HRT.

Authors: Lianne Lacroix
Journal: CMAJ Date: 2002-11-12 Impact factor: 8.262

2. What type of exercise prevents cardiovascular disease in postmenopausal women?

Authors: Christine Rivet
Journal: CMAJ Date: 2003-02-04 Impact factor: 8.262

3. Combination hormone replacement therapy and dementia.

Authors: Eric Wooltorton
Journal: CMAJ Date: 2003-07-22 Impact factor: 8.262

4. Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia.

Authors: Sheba M J MohanKumar; Badrinarayanan S Kasturi; Andrew C Shin; Priya Balasubramanian; Ebony T Gilbreath; Madhan Subramanian; Puliyur S Mohankumar
Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-12-22 Impact factor: 3.619

5. Notoginsenoside R₁ prevents H9c2 cardiomyocytes apoptosis against hypoxia/reoxygenation via the ERs/PI3K/Akt pathway.

Authors: Guang Li; Xiaoyan Xing; Yun Luo; Xuehong Deng; Shan Lu; Shimin Tang; Guibo Sun; Xiaobo Sun
Journal: RSC Adv Date: 2018-04-13 Impact factor: 4.036

Review 6. Protective actions of 17β-estradiol and progesterone on oxidative neuronal injury induced by organometallic compounds.

Authors: Yasuhiro Ishihara; Takuya Takemoto; Atsuhiko Ishida; Takeshi Yamazaki
Journal: Oxid Med Cell Longev Date: 2015-03-01 Impact factor: 6.543

7. The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women.

Authors: I Csizmadi; J-P Collet; A Benedetti; J-F Boivin; J A Hanley
Journal: Br J Cancer Date: 2004-01-12 Impact factor: 7.640

7 in total